The Street Now
2023 Stock to Watch
Pressure BioSciences, Inc.
Stock Quote: OTCQB: PBIO
The Street Podcast, Latest News Coverage Listen and Look Now!
Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record Investor Call Scheduled for Tuesday May 16, 2023 at 4:30 p.m. ET
Coverage Initiated: Strong Buy Recommended
“We feel that at current levels these shares could again test their 52 Week High of $2.40/share in the near future.” Serious investors should place these shares on their BUY LIST, read more.
Pressure BioSciences, Inc. OTCQB: PBIO PBIO’s Ultra Shear Technology for Nanoemulsion Processing Targets New Generation of High Performance, “Green” Agrochemicals for Worldwide Distribution into Food Production Markets, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries. Read more.
Corporate Website Featured Article Investor Presentation
News And Headlines
May 16, 2023 Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record Investor Call Scheduled for Tuesday May 16, 2023 at 4:30 p.m. ET
May 10, 2023 Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
May 9, 2023 Pressure BioSciences UltraShear Processed Nano-THC Oral Spray Results Reported
April 26, 2023 Pressure BioSciences Updates Rapid Progress on Limited Offering of Exclusive THC Licenses for Revolutionary UltraShear Nanoemulsion Processing Platform
April 21, 2023 Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform
April 18, 2023 Pressure BioSciences Announces Expansion into Strategic Manufacturing Facilities with Premier Process Technologies Company, Artisan Industries
April 14, 2023 Pressure BioSciences, Reports 2022 Financials and 2023 Revenue Guidance Business Update; Seeking Alpha: Pressure BioSciences (OTCQB: PBIO) 2022 Revenues Up 90.6% Y/Y
April 13, 2023 Pressure Biosciences Investor Call 4:30 pm ET Tuesday, April 18, 2023
March 28, 2023 Pressure BioSciences Reports Fresh Sales Momentum for PBI Agrochem
March 22, 2023 Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified; Seeking Alpha Pressure BioSciences lands $1.5M order for its UltraShear Nanoemulsified CBD
March 21, 2023 Pressure BioSciences Emerging Growth Conference on March 22, 2023 1.40pm
March 1, 2023 Breaking News Pressure BioSciences Exchanges $10M+ Debt for Equity
February 24, 2023 Benzinga Reports on Pressure BioSciences’ Breakthrough UltraShear Nanoemulsion Revolutionizing The Edible Cannabis Industry
February 1, 2023 Pressure BioSciences Receives Record Nearly $600,000 Order for 16 PCT Instruments Largest Single Order in Company’s History “Prepaid” from New Chinese Distributor; Seeking Alpha Reports Pressure BioSciences bags largest single order for 16 PCT instruments
January 27, 2023 Pressure BioSciences and One World Products Announce Partnership in Development of CBD-Nanoemulsion Sports Performance/Recovery Drinks NBA Legend Isiah Thomas Leads Effort to Innovate and Deliver Next Generation Sports Drinks; Seeking Alpha Reports: Pressure BioSciences, One World team up to develop CBD sports performance drinks
January 19, 2023 Pressure BioSciences Nanoemulsions Platform Forging Game-Changing Future for Cannabis Industry
December 13, 2022 Pressure BioSciences First Commercial Production of Revolutionary UltraShear Nanoemulsion CBD Oral Spray $1M Revenues Expected 2023
November 22, 2022 Pressure BioSciences, Reports Q3 2022 Financials & Updates on Ultra Shear Technology Nanoemulsions Commercialization Progress
November 21, 2022 Pressure BioSciences, Inc. to Discuss Third Quarter 2022 Financial Results and Provide Business Update Conference Call Scheduled for Tuesday November 22 at 4:30pm ET
October 26, 2022 Pressure BioSciences and Cosmeceuticals Innovator Dr. Denese SkinScience to Introduce Revolutionary UST Nanoemulsion Hair Regrowth Product in 2023
October 11, 2022 Pressure BioSciences and Leading Cosmeceuticals Company Dr. Denese SkinScience Presented Their Partnership Progress in FORCE Family Office
September 28, 2022 Imminent Commercial Launch of Revolutionary UST Processing Method to be Focus of Pressure BioSciences Presentation at Emerging Growth Conference 40 on September 28, 2022
September 27, 2022 Pressure BioSciences’ UST Platform Illuminated at Conference of Food Engineering 2022
September 13, 2022 Pressure BioSciences Presentating Business Strategy at H. C. Wainwright Annual Global Investment Conference on September 13th Shifts Primary Business Focus to Revolutionary UST Platform
Pressure BioSciences’ Cosmeceuticals Partnership w/ Dr. Denese SkinScience, 20-
August 24, 2022 Pressure BioSciences’ Cosmeceuticals Partnership w/ Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales; Seeking Alpha Reports Pressure Biosciences partners with Dr. Denese Skinscience to develop skincare products
August 18, 2022 Pressure BioSciences Announces Contract for Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue
August 16, 2022 Pressure BioSciences to Discuss Second Quarter 2022 Financial Results and Business Update Conference Call Scheduled for Thursday August 18 at 4:30pm ET
August 11, 2022 Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
July 21, 2022 Pressure BioSciences Announces Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
July 14, 2022 Pressure BioSciences’ Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
June 1, 2022 Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast
May 24, 2022 Pressure BioSciences’ CEO Richard T. Schumacher Releases New TechTalks Video Interview
May 19, 2022 Pressure BioSciences, Inc. Reports Q1 2022 Financial Results Investor Call Scheduled for Thursday, May 19, 2022 at 4:30 p.m. ET ; Seeking Alpha Reports: Pressure BioSciences Reports Q1 2022 Financial Results
May 4, 2022 Pressure BioSciences Announces Nanoemulsions Manufacturing Agreement for UST Program w/ Safer Medical of Montana for CBD Topical Spray for Pain Reduction
May 3, 2022 Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022 Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT
April 27, 2022 Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing
April 20, 2022 Pressure BioSciences, Inc. Discusses Commercialization of Their Revolutionary UST Platform and Their Planned 2022 Uplisting with The Stock Day Podcast
April 5, 2022 Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022 Investor Conference Call Scheduled for Tuesday April 5 at 4:30 PM ET – Q4 and FY2021 Total Revenue Increased 91%
April 4, 2022 Benzinga Reports Pressure BioSciences’ PBI Novel Ultra High-Pressure, Intense Shear System Aims To Improve Food Quality And Safety
April 1, 2022 Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update Conference Call Scheduled for Tuesday, April 5 at 4:30pm ET
March 17, 2022 Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market
March 10, 2022 Emerging Technology “TechTalks” Interview’s Richard T. Schumacher, CEO Pressure BioSciences, Inc.
March 8, 2022 Benzinga Reports: PBI Achieves Major Commercialization Milestone As Innovative Pressure-Based UST Platform to Officially Entering The Market
March 3, 2022 Pressure BioScience Installs New Pilot-Scale Ultra Shear Technology Equipment at Ohio State University for Processing/Preparation of Higher Quality and Safer Liquid Foods and Beverages
February 3, 2022 Pressure BioSciences, Inc. Discusses 2022 Revenue Potential of Its Innovative and Enabling Ultra Shear Technology Platform with The Stock Day Podcast
January 27, 2022 Pressure BioSciences Ultra Shear Technology Commercialization Milestone: Production-Scale System Commissioned at Ohio State to Serve Food Industry
January 19, 2022 Pressure BioSciences to Participate in FORCE Family Office’s January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market
December 22, 2021 Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability UST Platform’s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets
November 17, 2021 Pressure BioSciences Q3 Financials Operational and Technical Achievements Major Growth and Profitability in 2022 Expected – Investor Call Wed, November 17, 2021, at 4:30 p.m. ET
November 11, 2021 Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve Ultra Shear Technology™ (UST™) Expected Profitability in 2022
November 4, 2021 Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology PBIO Benzinga Virtual ALL ACCESS Investor Event Today11/4/21 at 11:20 am ET.
November 2, 2021 Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021
October 1, 2021 Benzinga Reports: Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
September 30, 2021 Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use
September 29, 2021 Pressure BioSciences to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications
September 28, 2021 Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022
Pressure Biosciences’ CEO Presenting Plus Others at the Emerging Growth Conference on September 29 Register Now Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance
September 13, 2021 Pressure BioSciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces
September 9, 2021 Benzinga: Pressure BioSciences, Inc. Escalating Quarterly Revenue, Major Progress in Key Platform Technologies, and Formation of Eco-Friendly Agrochem Subsidiary that Already Posted Over $1 Million in Orders
August 26, 2021 Pressure BioSciences Reports Strong 2nd Quarter Financial and Business Results; Looks Forward to an Even Stronger 2nd Half of 2021
August 19, 2021 Pressure BioSciences Reports Significant Growth in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Q2 2021 Financials Investor Call Scheduled for Thursday, August 19, 2021 4:30 p.m. EDT
August 18, 2021 Pressure BioSciences to Host Q2 2021 Financial Results and Business Update on Thursday, August 19, 2021
August 17, 2021 Pressure BioSciences CEO to Expand on Recent Announcement of $1,000,000+ Eco Friendly Agrochem Subsidiary Order(s) Real-Time, Interactive PBI Agrochem Update and a Q&A Session, on Wednesday, August 18, 2021
August 17, 2021 PBIO CEO Presenting at Emerging Growth Conference on August 18. Register Now!
August 12, 2021 Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
August 5, 2021 Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches toward UST Commercial Release, Up-listing, and Profitability
July 28, 2021 Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21% – Pressure Biosciences Featured
July 21, 2021 Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary Subsidiary will House Announced Asset Acquisition from Global Agrochemicals Innovator
July 20, 2021 Pressure BioSciences to Expand on Recent UST Platform Breakthroughs and Impending Agrochem Asset Acquisition at Upcoming Emerging Growth Conference on Wednesday, July 21, 2021
July 20, 2021 CEO Presenting on the Emerging Growth / Investors Hub Joint Conference on July 21; Register Now Niche Companies in Technology, Gaming, Biotech, Exploration, Oil & Gas and more in Attendance
July 14, 2021 Pressure BioSciences Inc. CEO Featured on Benzinga’s Internationally Acclaimed Power Hour Luncheon
July 13, 2021 Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal; Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide
July 1, 2021 Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World’s Most Potent Antioxidants – Astaxanthin
June 22, 2021 Pressure BioSciences to Present at the Emerging Growth Conference
June 21, 2021 Pressure Bioscience Presenting on the First Emerging Growth / Investors Hub Conference Register Now Technology, Cryptocurrency & Blockchain, Biotech, Exploration
June 10, 2021 Pressure BioSciences to Present at the LD Micro Virtual Invitational Conference XI Individual and Institutional Investors, Advisor’s and Analysts, etc. to Attending on Thursday, June 10, 2021
May 19, 2021 Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update
May 18, 2021 Pressure BioSciences Sales Up Over 120%, Q1 2021 Financial Results and Business Update Call on Wednesday, May 19, 2021 Purchase of Accretive, Eco-Friendly Agrochemical Supplier
May 13, 2021 Pressure BioSciences Awarded Three Additional Patents for Revolutionary Ultra Shear Technology Platform Unique Commercial-Scale Capabilities for Highest-Quality Nanoemulsions of Oils in Water Enabled by PBI’s UST Platform, Addressing Multiple Billion Dollar Opportunities in Diverse Markets Worldwide
April 14, 2021 Pressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth, Leveraging Market-Changing Synergy from PBI’s Ultra Shear Technology Nanoemulsions Platform
March 15, 2021 Pressure BioSciences Discusses Partnerships with Leica Microsystems (Cancer Diagnostics) and Ohio State University (Food Industry Consortium) with The Stock Day Podcast
March 4, 2021 Transformative Impact for Food Industry Consortium Formed by Pressure BioSciences and The Ohio State University Discussed in Showcase Video from Emerging Technology Insider
February 24, 2021 Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI’s Ultra Shear Technology
February 24, 2021 How Nanoemulsion Technology Is Drastically Affecting the Food & Beverage Industry $KO $PEP $KHC $BYND $PBIO
February 8, 2021 Pressure BioSciences to Acquire International Global Eco-Friendly Company
January 20, 2021 Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety PBI Announces Collaboration to Improve and Optimize SinuSys Corp’s Lead Sinus Health Product Candidate for Commencement of Phase IIb Clinical Study
December 17, 2020 Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe
December 15, 2020 Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum
December 14, 2020 Pressure BioScience a Life Sciences Company to Broadcast Live on December 17th, 2020
December 4, 2020 Pressure BioSciences Announces Plans to Acquire Cannaworx, Inc. and Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster
December 3, 2020 Pressure BioSciences, Inc Highlighted in Blue Horse Shoe Stocks
December 2, 2020 Pressure BioSciences Inc. (PBIO) Looks to Provide Key to Commercial Success of Novel Products; Pressure BioSciences’ (PBIO) First Issued U.S. Patent for Its Novel UST Platform Advances the Company Toward 2021 Product Delivery, Significant Acceleration of Revenue, and Profitability
November 24, 2020 Pressure BioSciences, Inc. (PBIO) Reports Revenue Hike in Q3, While Achieving Its Best Financial Quarter in Two Years; Company Expects Strong 2021
November 18, 2020 Pressure BioSciences Inc. (PBIO) Announces Q3 2020 Financial Results, Provides Business Update
November 17, 2020 Pressure BioSciences, Inc. (PBIO) CEO Rick Schumacher on Q3 2020 Results – Earnings Call Transcript
November 16, 2020 Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update – Conference Call Scheduled for Tuesday, November 17th at 4:30pm ET
November 11, 2020 Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform
October 12, 2020 Pressure BioSciences (PBIO) Commercial Rollout of Revolutionary Nanoemulsification System
October 6, 2020 Pressure BioSciences Achieves Critical Milestone in Revolutionary Nanoemulsification Technology Development; Enters Production Era for Commercial System Development
August 12, 2020 Pressure BioSciences Awarded Pivotal U.S. Patent for Novel, High Pressure Enhanced Consumable Device
July 7, 2020 Pressure BioSciences First Quarter 2020 Financial and Business Update to Include Jim Morrison, In-Coming CEO for Merged Companies of Availa Bio
The Street Now is a leading publisher of today’s market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique opportunities for industry partnerships, corporate communications, market exposure and investment. We have been paid cash only for this report. We do not take shares in payment for our work.
A complete disclaimer can be viewed HERE
Statements & Policies
We never take shares as payment for our services. We are paid cash in advance of our initiating our marketing service for any company. We base any target price in conjunction with technical analysis and company management fore-knowledge and input.
Summary of Disclosures
- You should review the entirety of the following Statements & Policies, which include important information not included in this Summary of Disclosures. You should not rely solely on this summary.
- By accessing The Street Now (hereinafter referred to as “The Street Now” “we,” “us,” or “our”) website, you agree that you have reviewed and agree to the following Statements & Policies. If you do not agree to these Statements & Policies, you may not use the The Street Now website.
- The Street Now provides readers with information regarding publicly traded companies that have retained The Street Now to provide advertising, news and public relations services on their behalf. The Street Now receives compensation from the companies in the form of cash. The Street Now is neither an investment adviser nor a broker-dealer. The information presented in The Street Now’s website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. None of the information provided through this website constitutes a recommendation. Please consult with an independent investment adviser or other financial adviser before making an investment decision.
- The opinions and analysis included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith, but no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice.
- The Street Now and its owners, officers, directors, employees and affiliates may own, or may buy and sell, securities of companies profiled on the The Street Now’s website at any time before, during, or after distribution of information on the companies by The Street Now
Safe Harbor Statement
This website includes forward-looking statements pertaining to future anticipated plans, performance and development of the companies on whose behalf we disseminate information. Any statements on this website that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” “intends,” or other words or phrases of similar import. Similarly, statements in this website that describe a company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward–looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
CAUTIONARY DISCLAIMER STATEMENT: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the failure to satisfy the conditions of the Canadian Securities Exchange and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
By accessing The Street Now’s website, you signify your agreement to these Statements & Policies. If you do not agree to these Statements & Policies, you may not use The Street Now’s website. We reserve the right, at our sole discretion, to change, modify, add or delete portions of these Statements & Policies at any time. The Street Now’s website may contain many links to other websites, including paid advertisements, whose content is not managed by The Street Now. We do not endorse, nor are we responsible for, any of the content of those external websites.
All rights, including copyright, in the content of the The Street Now’s website are owned or controlled for these purposes by The Street Now. In accessing The Street Now’s website, you agree that you may only download and/or view the content for your own personal, non-commercial use. Except where expressly stated otherwise, without the prior written permission of The Street Now, you are not permitted to copy, broadcast, download, store (in any medium), transmit, show or play in public, adapt or change in any way the content of The Street Now’s website for any other purpose whatsoever.
This notice applies to all information collected or submitted on The Street Now’s website. On some pages, you can make requests and register to receive materials. The types of personal information collected at these pages are:
- Email address
- Phone number(s)
The Way We Use Information
We use the information you provide about yourself when responding to your requests for specific information. We occasionally share this information with outside parties we believe you would find of interest. We may be compensated by such parties for this service. We use return email addresses to answer the email we receive. You can register with our website if you would like to receive our periodic mailings as well as updates on our new products and services. Information you submit on our website will not be used for this purpose unless you fill out the registration form. We use non-identifying and aggregate information to better design our website and to share with advertisers. For example, we may tell an advertiser that X number of individuals visited a certain area on our website, or that Y number of men and Z number of women filled out our registration form. Finally, we never use or share the personally identifiable information provided to us online in ways unrelated to those described above without also providing you an opportunity to opt-out or otherwise prohibit such unrelated uses.
Our Commitment To Data Security
To prevent unauthorized access, maintain data accuracy, and ensure the correct use of information, we have put in place what we believe are appropriate physical, electronic, and managerial procedures to safeguard and secure the information we collect online. However, we make no guarantees or representations that such procedures will be effective and that all information will remain secure under all circumstances.
Our Commitment To Children’s Privacy
Protecting the privacy of children is especially important. For that reason, we never collect or maintain information at our website from individuals we actually know are under the age of 13, and no part of our website is structured to attract anyone under the age of 13.
How You Can Access or Correct Your Information
You can access all your personally identifiable information that we collect online and maintain by editing your user profile. We use this procedure to better safeguard your information. You can correct factual errors in your personally identifiable information by sending us a request that credibly shows error. To protect your privacy and security, we will also take reasonable steps to verify your identity before granting access or making corrections.
The Street Now “Tip of the Day” Disclaimer
The Street Now is not a registered investment advisor. The information contained on this site is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented on this recorded line is provided for informational purposes only and is not to be treated as advice to make any specific investment. Please consult with an independent investment advisor before making an investment decision. Neither The Street Now nor its officers, directors, partners, employees, consultants nor anyone involved in this site is a registered investment adviser or broker/dealer and none of the foregoing make any recommendation that the purchase of securities of any company profiled on this site is suitable or advisable for any person or that an investment in such securities will be profitable. Past performance of profiled securities is not indicative of future results. Companies profiled on this site line may lack an active trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Anyone investing in these companies should be able and prepared to bear a loss of his or her entire investment.
The Street Now Rating Disclaimer
The Street Now strives to ensure that all content and information published at this web site is current and accurate. The information and ratings at The Street Now does not in any way constitute legal or professional advice and The Street Now cannot be held liable for actions arising from its use. These ratings are based on The Street Now opinion ONLY and these ratings are NOT a recommendation to BUY and or SELL any SEC regulated public company. In addition The Street Now cannot be held responsible for the contents of any externally linked pages. Reference within this site to any specific commercial or non-commercial company, newsletter, product, process, or service by trade name, trademark, or otherwise does not constitute or imply an endorsement, recommendation, or favoring by The Street Now.
The Street Now Educational Resources Disclaimer
Online Broker Reviews are provided for general information purposes only and should not be considered an individualized recommendation or advice.
The Street Now DOES NOT receive any compensation from any of the online brokerage firms reviewed in this Educational Resources – Online Broker Reviews.
Email and Instant Message Policy
Information Regarding Securities and Market Data. The Street Now does not guarantee any information regarding securities issues and market data contained in an email to or from its employees, agents, or affiliates.
Email and Instant Message (IM) Security. The Street Now is not responsible for any damages resulting from a third party intercepting or otherwise obtaining an email, or the information contained within an email, sent to or from The Street Now, its employees, agents, or affiliates. For your protection, do not include account numbers, social security numbers, credit card numbers, passwords or any other non-public information in your email or IM.
Monitoring and Confidentiality of Email and Instant Messaging (IM). The Street Now may monitor email and IM communications addressed to the firm and any of its employees. The Street Now reserves the right to monitor such communications and does not guarantee the confidentiality of any transmission.
The Street Now’s website provides readers with information regarding publicly traded companies that have retained The Street Now to provide advertising, news and public relations services on their behalf. The Street Now receives compensation from the companies or affiliates in the form of cash only and do not except securities for conpensation. Such compensation, especially compensation in the form of securities, may create an actual or potential conflict of interest. In addition, to the extent that parties, including the companies discussed, investors or others, further disseminate content or other statements provided by The Street Now, such parties operate outside of The Street Now’s control. Such further dissemination may not be accompanied by appropriate disclaimers or other disclosures, and The Street Now assumes no responsibility for any such statements or dissemination.
Because The Street Now receives compensation for disseminating information, we may have a conflict of interest in terms of disseminating negative information about the companies that retain us. Readers should consider this in reaching their independent decision as to how to use the information contained in The Street Now’s website.
It is the practice of The Street Now to sell all securities received as compensation upon the expiration of the applicable holding period set forth in Rule 144 under the Securities Act of 1933 (Rule 144), notwithstanding the fact that The Street Now may be advertising or distributing materials on such securities and their issuers at the time of the sale of such securities. More generally, The Street Now may sell any securities that it holds at any time that it legally may do so, as it deems appropriate.
In addition, writers and editors who provide or review content contained on The Street Now’s website may buy, sell or maintain positions in securities of the companies discussed on The Street Now’s website. Such trading, which necessarily reflects an individual’s personal resources and financial condition, may be inconsistent with statements on The Street Now’s website.
Neither The Street Now nor its officers, directors, partners, employees, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker/dealer and none of the foregoing make any recommendation that the purchase of securities of any company profiled in the The Street Now’s website is suitable or advisable for any person or that an investment in such securities will be profitable. The information contained in the The Street Now’s website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the The Street Now’s website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser before making an investment decision.
The opinions and analysis included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith, but no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice. The Street Now shall not be liable for any errors or any actions taken in reliance thereon. Statements of opinion and belief are those of the authors and/or editors of this website, and are based solely upon the information possessed by such authors and/or editors; no inference should be drawn that The Street Now or such authors or editors have any special or greater knowledge about the companies profiled or any particular expertise in the industries or markets in which the profiled companies operate and compete.
Factual information on this website is obtained from public filings and other sources deemed to be reliable; however, The Street Now takes no responsibility for verifying the accuracy of such information and makes no representation that such information is accurate or complete. Certain statements included in this website may be forward-looking statements based on current expectations. The Street Now makes no representation and provides no assurance or guaranty that such forward -looking statements will prove to be accurate. Persons using the The Street Now website are urged to consult with independent financial advisers with respect to an investment in any company profiled herein. Investors should independently verify information provided in the The Street Now’s website by completing their own due diligence on any company in which they are contemplating an investment and review a complete information package on that company, which should include, but not be limited to, the company’s annual reports, quarterly reports, press releases, and regulatory filings.
Past performance of profiled securities is not indicative of future results. Companies profiled in this website may lack an active trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Anyone investing in these companies should be able and prepared to bear a loss of his or her entire investment. The information on this website is not designed to be used as the sole basis for an investment decision. Persons using the The Street Now’s website should confirm to their own satisfaction the veracity of any information prior to entering into any investment. The decision to buy or sell any security of a company that may be featured by The Street Now is done purely at the reader’s own risk. Under no circumstances will The Street Now owners, officers, directors, partners, employees, consultants or other persons involved in the publication of this website be held liable for any losses incurred by the use of information contained in this website.
The Street Now and its owners, officers, directors, employees and affiliates may own, or may buy and sell, securities of companies profiled in this website at any time before, during, or after distribution of information on the companies by The Street Now. The Street Now and its employees and affiliates may profit in the event the shares of the companies increase in value. Such securities may be sold from time to time even after The Street Now has distributed positive information regarding the companies. The Street Now does not guarantee that it will purchase the securities of profiled companies. The Street Now has no obligation to inform readers of its trading activities or the trading activities of any of its employees and/or affiliates.
The Street Now from time to time enters into agreements to purchase securities of publicly traded companies to provide financing to these companies.
The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. None of the information provided through this website constitutes a recommendation that any investment or trading strategy is suitable for any person. Persons should consult with their financial advisers before making any investment decisions.
THERE CAN BE NO ASSURANCE THAT THE CONTENT PUBLISHED ON THIS SITE IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT EXPRESSLY ASSUMES ALL RISKS FROM USING THE CONTENT. In particular, The Street Now does not guarantee it reviews, and is not responsible for confirming, the accuracy of issuer documents and information submitted for inclusion on this site. The issuer and its management are primarily responsible for the accuracy of any information regarding the issuer provided on this site. INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.
Because many securities traded over-the-counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security may not even be possible within a reasonable period of time.
Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security.
Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system or the Yellow Sheets does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.
The Street Now’s website may contain articles and other content submitted by third parties, including, but not limited to, articles submitted through the The Street Now Premium Partnership Program. The opinions and other statements expressed by such third parties are theirs alone and do not express the views and opinions of The Street Now or its affiliates. Content created by third parties is the sole responsibility of such third parties and its accuracy and completeness are not endorsed or guaranteed by The Street Now. You acknowledge that by providing you with the ability to view third-party content through our site, The Street Now is not undertaking any obligation or liability relating to such third-party content. The Street Now and its affiliates, successors, assigns, officers, directors, partners and employees assume no responsibility or liability that may arise from the third party content, including, but not limited to, claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation. Notwithstanding the foregoing, The Street Now reserves the right to remove third-party content at any time in its sole discretion.